PHARMA MAR - Daily - Technical analysis published on 07/08/2024 (GMT)
- 147
- 0
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Additional analysis
Quotes
The PHARMA MAR rating is 34.74 EUR. The price registered an increase of +4.07% on the session and was between 33.38 EUR and 35.12 EUR. This implies that the price is at +4.07% from its lowest and at -1.08% from its highest.Here is a more detailed summary of the historical variations registered by PHARMA MAR:
Near a new LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
A technical analysis in Daily of this PHARMA MAR chart shows a strongly bullish trend. The signals given by moving averages are 85.71% bullish. This strongly bullish trend seems to be running out of steam given the signals being given by short-term moving averages. The Central Indicators scanner detects bullish signals on moving averages that could impact this trend:
Bullish trend reversal : adaptative moving average 100
Type : Bullish
Timeframe : Daily
Bullish price crossover with Moving Average 20
Type : Bullish
Timeframe : Daily
Bullish price crossover with Moving Average 50
Type : Bullish
Timeframe : Daily
Bullish price crossover with adaptative moving average 20
Type : Bullish
Timeframe : Daily
Bullish price crossover with adaptative moving average 50
Type : Bullish
Timeframe : Daily
An assessment of technical indicators shows a moderate bullish signal.
But beware of excesses. The Central Indicators scanner currently detects this:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Weekly
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Daily
RSI indicator is back over 50
Type : Bullish
Timeframe : Daily
Aroon indicator bullish trend
Type : Bullish
Timeframe : Daily
Ichimoku : price is over the cloud
Type : Bullish
Timeframe : Daily
Momentum indicator is back over 0
Type : Bullish
Timeframe : Daily
An analysis of the price chart with the Central Patterns scanner (detector of chart patterns and resistances and supports) shows a result that can have an impact on the price change:
Near support of triangle
Type : Bullish
Timeframe : Daily
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 28.21 | 30.91 | 32.88 | 34.74 | 35.26 | 37.88 | 41.18 |
Change (%) | -18.80% | -11.02% | -5.35% | - | +1.50% | +9.04% | +18.54% |
Change | -6.53 | -3.83 | -1.86 | - | +0.52 | +3.14 | +6.44 |
Level | Major | Minor | Intermediate | - | Intermediate | Major | Minor |
Attention could also be paid to pivot points to set price objectives:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 32.26 | 32.70 | 33.04 | 33.48 | 33.82 | 34.26 | 34.60 |
Camarilla | 33.17 | 33.24 | 33.31 | 33.38 | 33.45 | 33.52 | 33.60 |
Woodie | 32.21 | 32.68 | 32.99 | 33.46 | 33.77 | 34.24 | 34.55 |
Fibonacci | 32.70 | 33.00 | 33.18 | 33.48 | 33.78 | 33.96 | 34.26 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 30.09 | 30.97 | 32.17 | 33.05 | 34.25 | 35.13 | 36.33 |
Camarilla | 32.81 | 33.00 | 33.19 | 33.38 | 33.57 | 33.76 | 33.95 |
Woodie | 30.26 | 31.05 | 32.34 | 33.13 | 34.42 | 35.21 | 36.50 |
Fibonacci | 30.97 | 31.76 | 32.25 | 33.05 | 33.84 | 34.33 | 35.13 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 23.09 | 27.45 | 29.64 | 34.00 | 36.19 | 40.55 | 42.74 |
Camarilla | 30.02 | 30.62 | 31.22 | 31.82 | 32.42 | 33.02 | 33.62 |
Woodie | 22.00 | 26.91 | 28.55 | 33.46 | 35.10 | 40.01 | 41.65 |
Fibonacci | 27.45 | 29.96 | 31.50 | 34.00 | 36.51 | 38.05 | 40.55 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
RSI (14): | 55.96 | |
MACD (12,26,9): | -0.4000 | |
Directional Movement: | 3.29 | |
AROON (14): | 42.86 | |
DEMA (21): | 33.38 | |
Parabolic SAR (0,02-0,02-0,2): | 31.86 | |
Elder Ray (13): | 0.70 | |
Super Trend (3,10): | 35.49 | |
Zig ZAG (10): | 34.80 | |
VORTEX (21): | 0.8100 | |
Stochastique (14,3,5): | 58.46 | |
TEMA (21): | 32.60 | |
Williams %R (14): | -9.70 | |
Chande Momentum Oscillator (20): | 0.36 | |
Repulse (5,40,3): | 3.4400 | |
ROCnROLL: | 1 | |
TRIX (15,9): | -0.1800 | |
Courbe Coppock: | 10.35 |
MA7: | 32.88 | |
MA20: | 33.93 | |
MA50: | 34.28 | |
MA100: | 31.63 | |
MAexp7: | 33.44 | |
MAexp20: | 33.81 | |
MAexp50: | 33.64 | |
MAexp100: | 33.33 | |
Price / MA7: | +5.66% | |
Price / MA20: | +2.39% | |
Price / MA50: | +1.34% | |
Price / MA100: | +9.83% | |
Price / MAexp7: | +3.89% | |
Price / MAexp20: | +2.75% | |
Price / MAexp50: | +3.27% | |
Price / MAexp100: | +4.23% |
News
The last news published on PHARMA MAR at the time of the generation of this analysis was as follows:
- Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants
- PharmaMar and Jazz Pharmaceuticals Announce Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca® (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell Lung Cancer
- PharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in Taiwan
- Jazz Pharmaceuticals and PharmaMar Announce Results of ATLANTIS Phase 3 Study Evaluating Zepzelca™ in Combination with Doxorubicin for Patients with Small Cell Lung Cancer Following One Prior Platinum-containing Line
- PharmaMar Announces the U.S. FDA Approval of lurbinectedin (Zepzelca™) for the Treatment of Metastatic Small Cell Lung Cancer
Add a comment
Comments
0 comments on the analysis PHARMA MAR - Daily